May 30, 2026 08:00AM
Apr 20, 2026 06:45AM
Apr 20, 2026 06:45AM
Mar 19, 2026 06:45AM
Feb 27, 2026 10:04AM
Feb 27, 2026 10:00AM
Feb 23, 2026 05:00PM Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer
Dec 17, 2025 06:45AM
Nov 21, 2025 01:24PM
Nov 21, 2025 01:24PM
Oct 19, 2025 04:15AM
Oct 18, 2025 10:30AM
Aug 12, 2025 05:30AM
Jul 17, 2025 12:00AM Astellas Announces a Partnership with the "Korea Institute of Startup and Entrepreneurship Development", an Umbrella Organization of the "Ministry of SMEs and Startups", a Korean G
Jul 17, 2025 12:00AM
Jul 10, 2025 06:45AM
May 22, 2025 05:05PM
May 22, 2025 05:00PM
Feb 13, 2025 10:00AM
Feb 12, 2025 06:32PM
Feb 10, 2025 05:01PM Pfizer (PFE) and Astellas PADCEV plus KEYTRUDA Shows Long-Term Efficacy in First-Line Treatment of la/mUC
Feb 10, 2025 05:00PM
Jan 8, 2025 06:30PM
Oct 10, 2024 06:51AM
May 21, 2024 12:00AM
Jan 26, 2024 12:01PM
Jan 26, 2024 12:00PM
Jan 26, 2024 12:00PM European Medicines Agency Validates Type II Variation Application for PADCEV™ (enfortumab vedotin) with KEYTRUDA®(pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer
Jan 8, 2024 06:30PM
Jan 8, 2024 10:35AM
Dec 21, 2023 06:30PM
Dec 15, 2023 05:00PM
Nov 16, 2023 10:33PM
Nov 15, 2023 06:37PM
Aug 23, 2023 06:45AM FDA Grants Priority Review for XTANDI® in Non-Metastatic Castration-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence
Jun 20, 2023 06:34PM
Apr 30, 2023 09:24PM
Apr 30, 2023 07:00PM
Apr 30, 2023 07:00PM
Apr 29, 2023 10:45AM
Mar 16, 2023 07:30PM
Feb 19, 2023 06:30PM Astellas Provides Update on Fezolinetant New Drug Application in U.S.
Feb 16, 2023 10:00AM
Oct 4, 2022 06:45AM
Aug 18, 2022 02:30AM
Sep 20, 2021 05:46AM
Sep 17, 2021 06:05PM
Jun 23, 2021 06:45AM
May 29, 2020 08:20AM Pfizer (PFE), Astellas Announce Final PROSPER Results Show XTANDI Significantly Extends OS in Men with Non-Metastatic Castration-Resistant Prostate Cancer
May 29, 2020 08:00AM

1,198,731 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All